AstraZeneca’s Saphnelo (SC) administration has shown a decrease in disease activity in individuals with systemic lupus ...

Trially has raised $4.7m in a seed funding round and introduced its agentic AI solution, Margo, designed to increase study ...

On this episode, the healthcare editorial team unpicks several key trials and trends from this year’s event, held from 29 ...

Amidst significant shifts in the pharmaceutical industry, the number of clinical trials has surged over the first half of ...

Despite missing the primary endpoint, aTyr Pharma still sees a future for the drug as it plans further FDA discussions.

PhaseV has entered into a strategic partnership with Bioforum to enhance the efficiency of clinical trials using advanced ...

REDCap Cloud (nPhase) has introduced a new platform to unify real-world evidence with clinical study data within a single system.

Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) ...

Takeda’s readout comes from two pivotal Phase III trials of its OX2R, with Alkermes’ data coming from a Phase II trial in NT1 ...

In the head-to-head trial, Lilly’s oral drug emerged on top, outperforming Novo Nordisk’s semaglutide.

Revolution will now explore daraxonrasib’s potential as a monotherapy and in combination with chemotherapy in late-stage PDAC trials.

In August, Regeneron announced positive results from Phase III clinical trial NIMBLE evaluating the efficacy and safety of pozelimab + cemdisiran combination therapy and cemdisiran monotherapy for ...